Drugs News and Research

RSS

Fred Hutch’s new Evergreen Fund to promote commercialization of research into lifesaving therapies

Fred Hutchinson Cancer Research Center announced its first-ever grants from its newly established Evergreen Fund to spur researchers' efforts to advance bold ideas toward creating or partnering with a commercial entity.

28 Dec 2016

Research reveals how microbial context during infectious disease can compromise antibiotic therapy

Bacteria that are susceptible to antibiotics can survive when enough resistant cells around them are expressing an antibiotic-deactivating factor.

28 Dec 2016

Military health system to test U-M-developed V-BID approach

A health care reform idea originated by University of Michigan faculty will get a major test among members of the nation's military and their families, thanks to a provision in the national defense spending bill signed by President Obama on Friday.

28 Dec 2016

Combination of diabetes and hypertension drugs can effectively treat cancer

A combination of a diabetes medication and an antihypertensive drug can effectively combat cancer cells.

27 Dec 2016

Scientists identify sugar molecule that reduces inflammatory response and COPD progression

Using a mouse model, scientists from the RIKEN-Max Planck Joint Research Center for Systems Chemical Biology and a number of other institutes have identified a sugar molecule that reduced the inflammatory response and progress of emphysema, a common component of chronic obstructive pulmonary disease (COPD).

27 Dec 2016

Reduced radiation can maintain high cure rates in patients with HPV-related oropharyngeal cancers

Human papillomavirus-positive oropharynx cancers (cancers of the tonsils and back of the throat) are on rise.

27 Dec 2016

Potential drug could become first effective treatment option for Prader-Willi syndrome

Duke Health researchers have identified a drug-like small molecule that, in animal experiments, appears to be an effective treatment for a genetic disorder called Prader-Willi syndrome.

27 Dec 2016

Whitehead Institute researchers identify mechanism underlying cancer drug-resistance

The use of proteasome inhibitors to treat cancer has been greatly limited by the ability of cancer cells to develop resistance to these drugs.

27 Dec 2016

C elegans could be powerful model for understanding how nervous systems produce behaviors

The human brain, the most complex object in the universe, has 86 billion neurons with trillions of yet-unmapped connections.

27 Dec 2016

New discovery could lead to effective drugs to prevent excessive lymphatic growth in cancer

Cancer cells spread to other sites in the body through promoting the growth of new 'roads' to travel on.

27 Dec 2016

Experimental drug improves survival, growth outcomes in mouse model of Prader-Willi syndrome

Drugs capable of activating silenced genes improve survival and growth outcomes in a mouse model of Prader-Willi syndrome, a rare and incurable childhood disease, according to a study funded by the National Institutes of Health.

27 Dec 2016

Saint Louis University geriatrician urges older patients to talk to doctors about too many pills

If you're 65 or older and taking more than four medications, resolve to talk to your doctor about doing a New Year's triage to make sure too many pills aren't making you sick, advises Milta Little, D.O., associate professor of geriatrics at Saint Louis University.

26 Dec 2016

Ionis announces FDA approval of first SMA drug in the U.S for pediatric and adult patients

Ionis Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration has approved SPINRAZATM (nusinersen) under Priority Review for the treatment of spinal muscular atrophy (SMA) in pediatric and adult patients.

26 Dec 2016

Gulf Breeze Recovery underscores importance of high-quality programs for treating opioid addiction

As opioid addiction hits record highs, Gulf Breeze Recovery, a Florida-based addiction recovery center, stresses the importance of high-quality, successful programs for treating addiction.

26 Dec 2016

OTC medical device receives CE Mark approval to treat pain linked to fibromyalgia

AVACEN Medical announced its AVACEN 100, Class-IIa, OTC medical device has received the CE Mark approval to treat widespread pain associated with fibromyalgia.

23 Dec 2016

MDA celebrates FDA approval of new spinal muscular atrophy drug

The Muscular Dystrophy Association today celebrated news of the U.S. Food and Drug Administration's decision to grant approval for nusinersen (brand name Spinraza), the first disease-modifying drug to treat the most common genetic cause of death in infants.

23 Dec 2016

Study shows three-drug combination delays recurrence and lengthens life for myeloma patients

The International Myeloma Foundation today announced the publication in The Lancet of the results of a randomized, phase III trial, conducted by SWOG, a publicly funded international cancer clinical trials network, and led by IMF chairman of the board Brian G.M. Durie, MD.

23 Dec 2016

Drugs News and Research

Fred Hutch’s new Evergreen Fund to promote commercialization of research into lifesaving therapies

Research reveals how microbial context during infectious disease can compromise antibiotic therapy

Military health system to test U-M-developed V-BID approach

Combination of diabetes and hypertension drugs can effectively treat cancer

Scientists identify sugar molecule that reduces inflammatory response and COPD progression

Reduced radiation can maintain high cure rates in patients with HPV-related oropharyngeal cancers

Potential drug could become first effective treatment option for Prader-Willi syndrome

Whitehead Institute researchers identify mechanism underlying cancer drug-resistance

C elegans could be powerful model for understanding how nervous systems produce behaviors

New discovery could lead to effective drugs to prevent excessive lymphatic growth in cancer

Experimental drug improves survival, growth outcomes in mouse model of Prader-Willi syndrome

Saint Louis University geriatrician urges older patients to talk to doctors about too many pills

Ionis announces FDA approval of first SMA drug in the U.S for pediatric and adult patients

Gulf Breeze Recovery underscores importance of high-quality programs for treating opioid addiction

OTC medical device receives CE Mark approval to treat pain linked to fibromyalgia

MDA celebrates FDA approval of new spinal muscular atrophy drug

Study shows three-drug combination delays recurrence and lengthens life for myeloma patients

FDA approves first drug to treat children and adults with spinal muscular atrophy

Personal fish calculator reveals safety of seafood

Study highlights barriers to HIV care in sub-Saharan Africa

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News